Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the site footer; the funding notice and Revision: v3.4.1 text were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded a glossary display ('Show glossary') and updated the revision to v3.4.0. Adjusted FEAR Act labeling (No FEAR Act Data / No FEAR Act data) and QC metadata entries (Last Update Submitted that Met QC Criteria) with removal of the older version entry.SummaryDifference0.2%

- Check56 days agoChange DetectedA minor version update from Revision: v3.3.3 to Revision: v3.3.4 was applied, with no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedA Maryland location is added under the Locations section, and the previous Maryland Locations heading is removed as part of revision v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.